Dec 16 2009

Oxygen Biotherapeutics’ oxygen therapy products in development for traumatic brain injury, stroke, heart attack, and many other biomedical applications


Guests: Dr. Chris Stern, Chairman and CEO, and Deb Thompson, Sr. VP Clinical Affairs, Oxygen Biotherapeutics, Inc., Durham

sternphoto.jpg
Dr. Chris Stern, Chairman & CEO, Oxygen Biotherapeutics, Inc.
thompsonphoto.jpg
Deb Thompson, Sr. VP, Clinical Affairs, Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc.

DERMACYTE Oxygen Concentrate Gel

Advertisement

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s